Pharmacy-funded enterprises inviting business to make a transition should not be "children's play"

After a period of adjustment in the pharmaceutical industry, the survival of the fittest by pharmaceutical investment merchants has become the main theme of the market. In particular, in the last two years, as the country has vigorously rectified the pharmaceutical industry, investment companies that rely on simple inputs, opportunistic acquisitions, and even illegal operations have gradually been eliminated by the market, and replaced by a number of strong pharmaceutical investment enterprises with clear positioning and standardized business practices. The rise.

In the pharmaceutical investment industry, with the implementation of policies such as medical reform, the pharmaceutical market is also changing. For this reason, for pharmaceutical investment promotion, if pharmaceutical investment companies want to survive, they must transform and take the “new investment promotion” road. With the development of the industry and social changes, the pharmaceutical investment industry is facing a “shuffle” and the pharmaceutical industry will face a series of market integration. One of the outstanding performances of this integration is that it will generate mergers and reorganizations within the industry, and through the continuous inter-regionalization of regional advantages, it will really promote the emergence of super-investing companies in the industry, and will be promoted through the guidance of such group-based and large-scale pharmaceutical investment enterprises. The improvement of the business level of the entire industry.

When China's pharmaceutical industry has entered a new era with channels and deep marketing and professional marketing as the core, the entire industry environment is rapidly following this direction. How the future of the pharmaceutical investment promotion road should go, and the search for a suitable transformation path is the key to whether an enterprise can survive and develop.

As a pharmaceutical investment enterprise, under the traditional telemarketing model, there are no detailed requirements for the investment personnel to grasp the drug research or the pharmaceutical industry. In the eyes of the investment enterprises, as long as they have strong communication skills and relationship building levels, they can do business and expand their business. Of course, it is undeniable that such business ideas have indeed achieved very good results in the early stages of investment promotion in medicine, and have created a large number of successful pharmaceutical investment companies and successful individuals. However, with the return of the nature of the industry and the public and agents’ attention to information on drug safety, high-end talents who are familiar with the characteristics of drugs, conduct detailed market research, and have the ability to accurately grasp the industry have gradually gained industry recognition.

In the face of this dilemma, there are two transitional roads that can be considered by pharmaceutical investment merchants. One is the acquisition of pharmaceutical companies and the other is the implementation of strategic alliances. Specifically, compared to a powerful pharmaceutical and commercial enterprise, it is possible to choose a manufacturer that is suitable for selling its own products, and to turn the manufacturer into its own product supply base through mergers and acquisitions and holdings.

Pharmaceutical Agency Network Analysis In the growing pharmaceutical market, pharmaceutical investment agency companies need to start from the fundamentals of the pharmaceutical market and the development of channels to adapt to changes in the times. In the new era, it is necessary to take the “new investment promotion” road. In particular, business investment promotion companies with product agents as the core are faced with a more intense market competition pattern. In order to maintain the development of pharmaceutical investment enterprises, in addition to rationally building several star products, it is necessary to make timely adjustments and improvements to existing products.